Answers are grounded in this paper and cite their sources.
Molecular imaging is a multimodality discipline for noninvasively visualizing biologic processes at the subcellular level. Clinical applications of radionuclide-based molecular imaging for breast cancer continue to evolve. Whole-body imaging, with scintimammography and PET, and newer dedicated breast imaging systems are reviewed. The potential clinical indications and the challenges of implementing these emerging technologies are presented.
No takes yet. Share an insight, caveat, or question.
Amy M. Fowler (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: